AstraZeneca, Daiichi Sankyo win first U.S. approval for key cancer drug
A drug from AstraZeneca and Daiichi Sankyo won authorization for a form of breast cancer, the first U.S. approval for the closely watched treatment.
A drug from AstraZeneca and Daiichi Sankyo won authorization for a form of breast cancer, the first U.S. approval for the closely watched treatment.
Veterinarians and pet owners are reporting adverse events associated with the use of Librela, a drug made by Zoetis to manage osteoarthritis pain in dogs,…
While many focus on AI’s role in customer service chatbots or network monitoring capabilities, the underlying changes run deeper: AI will help alter how telecom…
Many people wish not only to live as long as possible, but above all to do so without any health restrictions. However, with increasing age,…
New research outlines the benefits of normothermic ex-situ machine perfusion for surgeons and patients, including increased confidence about liver quality, shorter waitlist times and fewer…
Spot uses AI trained on 1,200 photos to identify graffiti sprayers, alerting staff who verify and respond through live stream.
Panelists discuss how, despite being preventable and treatable, chronic obstructive pulmonary disease (COPD) has emerged as a major global health challenge due to widespread exposure…
OpenAI may be close to releasing an AI tool that can take control of your PC and perform actions on your behalf, if leaks are…
In recent years, electronics engineers worldwide have been trying to develop new hardware that could further boost the speed and efficiency of wireless communications. Digitally…
A team of roboticists at Sony Computer Science Laboratories Inc. and the NeuroPiano Institute, in Kyoto, reports that a robotic exoskeleton strapped to the top…
U.S. companies see risks in working with Taiwan as it tries to build a ‘democratic supply chain’